Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,590,800
+$13,628,900 QoQ
Shares Held
90,000
+67.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#285
of 3,149 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Employees Provident Fund Board holds $1,255,262,333 across 8 Drug Manufacturers - General names. AMGN ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
518,259 | $621,615,444 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,640,333 | $209,755,987 | |
| 3 | BIIB |
Biogen Inc.
|
704,196 | $152,148,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
535,502 | $68,812,007 | |
| 5 | JNJ |
Johnson & Johnson
|
266,023 | $67,561,861 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
488,657 | $61,736,925 | |
| 7 | ABBV |
AbbVie Inc.
|
163,093 | $41,040,722 | |
| 8 | AMGN |
Amgen Inc
This page
|
90,000 | $32,590,800 |
All Filings in AMGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,590,800 | 90,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $18,961,900 | 53,892 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $25,693,835 | 78,500 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $22,858,200 | 81,000 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $22,031,623 | 78,907 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $15,639,810 | 50,200 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $14,856,480 | 57,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $13,403,936 | 41,600 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $13,060,410 | 41,800 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $13,647,360 | 48,000 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $14,401,000 | 50,000 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $12,362,960 | 46,000 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $11,656,050 | 52,500 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $8,001,925 | 33,100 | Shares | Sole | 2026-03-18 | |
| 2020-03-31 | $8,088,521 | 39,898 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||